Smith & Nephew plc (SNN)

24,61 +0,16 (+0,65%) Al cierre: 04:00PM EDT

Smith & Nephew plc

Building 5
Croxley Park Hatters Lane
Watford WD18 8YE
United Kingdom
44 1923 477 100
https://www.smith-nephew.com

Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 18.452

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Dr. Deepak S. Nath Ph.D.	CEO & Director	4,66M	N/A	1972
Mr. John Terence Rogers	CFO & Executive Director	N/A	N/A	1969
Mr. Paul Connolly	President of Global Operations	N/A	N/A	1968
Mr. Andrew Swift	Vice President of Investor Relations	N/A	N/A	N/A
Ms. Helen Barraclough	Group General Counsel & Company Secretary	N/A	N/A	1979
Ms. Alison Parkes	Chief Compliance Officer & Compliance APAC	N/A	N/A	1972
Mr. Joe Metzger	Senior Vice President of Marketing Services & Communications	N/A	N/A	N/A
Mr. Philip G. Cowdy	Chief Corporate Development & Corporate Affairs Officer	N/A	N/A	1967
Ms. Elga Lohler	Chief Human Resources Officer	N/A	N/A	1968
Dr. Vasant Padmanabhan Ph.D.	President of Research & Development and Ear, Nose & Throat	N/A	N/A	1967

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Gobierno corporativo

El ISS Governance QualityScore de Smith & Nephew plc, a día 1 de abril de 2024, es 4. Las puntuaciones base son Auditoría: 8; Tablero: 2; Derechos de los accionistas: 1; Compensación: 7.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.